Our understanding of the structure and function of dystroglycan, a cel
l surface laminin/agrin receptor, has increased dramatically over the
past two years. Structural studies, analysis of its binding partners,
and targeted gene disruption have all contributed to the elucidation o
f the biological role of dystroglycan in development and disease. It i
s now apparent that dystroglycan plays a critical role in the pathogen
esis of several muscular dystrophies and serves as a receptor for a hu
man pathogen as well as being involved in early development, organ mor
phogenesis, and synaptogenesis.